The First Case of COVID-19 in the US Treated with Remdesivir Was in late January – Two Weeks Later China Was Mass Producing the Drug The first known case of COVID-19 showed up in the US in Washington state on January 19, 2020. The individual had traveled to visit family in Wuhan, China, and had returned on the 15th. The patient was immediately placed under surveillance and after declining health, he was finally given a drug being developed, remdesiver. Soon after treatment the individual recovered.The Washington State patient was lucky that the clinic that he first attended provided his samples to the CDC. It’s certainly unique that the patient was recommended remdesivir for treatment. He was then advertised as the first COVID-19 infected patient to recover after being treated with remdesivir. By mid-February a Chinese company started mass- producing remdesivir. Looking back, it’s curious how the doctors in Washington state became aware of the use of remdesivir for COVID-19. What information did they receive that would lead them to try this relatively unknown drug? Then how could the drug begin being mass-produced in China before trials even occurred in the US? Perhaps the answer is related to the firm that produces remdesivir, Gilead Sciences. Gilead is a large company that spends millions in its lobbying efforts annually. And just who, or what is Gilead Sciences? Gilead is partnered with Wuxi AppTec, an international pharmaceutical, biopharmaceutical and medical device company. Wuxi AppTec is owned in part by none other than America’s own – George Soros. Holding this web together is the fact that Gilead has endorsed and is engaged with a drug purchasing group, UNITAID. UNITAID is an outgrowth of the United Nations, Millennium Declaration of 2000, which is now the U.N. Global Compact. The large investors in UNITAID include WHO, George Soros, the Bill and Melinda Gates Foundation and a partnership relationship with the Clinton Health Access Initiative. Both Drs. Fauci and Birx are associated with the Clinton Health Access Initiative. The one person behind the promotion of Gilead’s remdesivir is the doctor who has worked with Gilead for a long time, Dr. Fauci. He also has downplayed and criticized the use of the much cheaper drug hydroxychloroquine. Can there be any uncertainty as to why Dr. Fauci, who worked closely with Gilead, is strongly promoting its more expensive and less effective medication, which has already failed against Ebola, over a readily available, markedly affordable medication with a 91% success rate? How long has the production of remdesivir been in the planning? Why is this drug so highly touted by Dr. Fauci? The answer appears to be related to Gilead Sciences.
My first question would be is the drug useful for Covid19. If the answer is yes I care not who endorses it. To my knowledge the early trials of hydroxychloriquine show no positive effect and in some people a negative effect. If hydrexcloriquine is shown to be helpful it should be used no matter who endorses it.
